270 related articles for article (PubMed ID: 21646541)
1. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis.
Ma X; Kumar M; Choudhury SN; Becker Buscaglia LE; Barker JR; Kanakamedala K; Liu MF; Li Y
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10144-9. PubMed ID: 21646541
[TBL] [Abstract][Full Text] [Related]
2. DMBA/TPA treatment is necessary for BCC formation from patched deficient epidermal cells in Ptch(flox/flox)CD4Cre(+/-) mice.
Uhmann A; Heß I; Frommhold A; König S; Zabel S; Nitzki F; Dittmann K; Lühder F; Christiansen H; Reifenberger J; Schulz-Schaeffer W; Hahn H
J Invest Dermatol; 2014 Oct; 134(10):2620-2629. PubMed ID: 24662765
[TBL] [Abstract][Full Text] [Related]
3. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
4. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC
Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292
[TBL] [Abstract][Full Text] [Related]
5. A multihit, multistage model of chemical carcinogenesis.
Owens DM; Wei S; Smart RC
Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development.
Lee H; Kim M; Baek M; Morales LD; Jang IS; Slaga TJ; DiGiovanni J; Kim DJ
Sci Rep; 2017 Mar; 7():45077. PubMed ID: 28322331
[TBL] [Abstract][Full Text] [Related]
7. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
8. Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.
Cataisson C; Ohman R; Patel G; Pearson A; Tsien M; Jay S; Wright L; Hennings H; Yuspa SH
Cancer Res; 2009 Jan; 69(1):319-28. PubMed ID: 19118017
[TBL] [Abstract][Full Text] [Related]
9. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
He G; Muga S; Thuillier P; Lubet RA; Fischer SM
Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
[TBL] [Abstract][Full Text] [Related]
10. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
11. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
Sutter C; Strickland JE; Welty DJ; Yuspa SH; Winter H; Schweizer J
Mol Carcinog; 1991; 4(6):467-76. PubMed ID: 1724371
[TBL] [Abstract][Full Text] [Related]
12. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
[TBL] [Abstract][Full Text] [Related]
13. CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.
Winkler AE; Brotman JJ; Pittman ME; Judd NP; Lewis JS; Schreiber RD; Uppaluri R
Cancer Res; 2011 Sep; 71(17):5707-16. PubMed ID: 21734014
[TBL] [Abstract][Full Text] [Related]
14. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
Murphy JE; Morales RE; Scott J; Kupper TS
J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes.
Indra AK; Castaneda E; Antal MC; Jiang M; Messaddeq N; Meng X; Loehr CV; Gariglio P; Kato S; Wahli W; Desvergne B; Metzger D; Chambon P
J Invest Dermatol; 2007 May; 127(5):1250-60. PubMed ID: 17301838
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.
Zhu S; Yoon K; Sterneck E; Johnson PF; Smart RC
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):207-12. PubMed ID: 11756662
[TBL] [Abstract][Full Text] [Related]
17. Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Wu L; Jiang H; Chawsheen HA; Mishra M; Young MR; Gerard M; Toledano MB; Colburn NH; Wei Q
Carcinogenesis; 2014 May; 35(5):1177-84. PubMed ID: 24503444
[TBL] [Abstract][Full Text] [Related]
18. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
19. Keratinocyte p38δ loss inhibits Ras-induced tumor formation, while systemic p38δ loss enhances skin inflammation in the early phase of chemical carcinogenesis in mouse skin.
Kiss A; Koppel AC; Anders J; Cataisson C; Yuspa SH; Blumenberg M; Efimova T
Mol Carcinog; 2016 May; 55(5):563-74. PubMed ID: 25753147
[TBL] [Abstract][Full Text] [Related]
20. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
